04:46 AM EDT, 09/05/2025 (MT Newswires) -- Bright Minds Biosciences ( DRUG ) said late Thursday it has entered an agreement with Piper Sandler and Cantor Fitzgerald to establish an at-the-market equity offering of up to $100 million.
The program will run for three years, the company said.
Bright Minds intends to use any funds raised for general corporate purposes, it said.